CBD News‎ > ‎

Cannabidiol NEWS

posted Dec 4, 2017, 4:06 AM by Scott Salisbury

Cannabidiol
Daily update  December 4, 2017
NEWS
Long-Term Trial Assesses Cannabidiol Safety, Efficacy in Patients with LGS
Long-term therapy of Lennox-Gastaut Syndrome (LGS) with cannabidiol (CBD) was found to sustain the reduction in total and drop seizure frequency as well as improve a patient's overall condition, according to results of an interim analysis of an open-label extension of two Phase 3 trials. Participants in ...
Google PlusFacebookTwitterFlag as irrelevant
Cannabidiol Effective for Reducing Drop Seizures in Lennox-Gastaut Syndrome Regardless of ...
WASHINGTON, DC – Add-on cannabidiol (CBD) for the treatment of Lennox-Gastaut syndrome (LGS) produces a clinically meaningful reduction in drop seizures regardless of whether patients are receiving concomitant clobazam or valproic acid, according to results presented at the 2017 American ...
Google PlusFacebookTwitterFlag as irrelevant
Zynerba Pharmaceuticals Announces New ZYN002 Data from STAR 1 and STAR 2 Studies in ...
In a poster presentation entitled, “Synthetic Transdermal Cannabidiol for the Treatment of Focal Epilepsy in Adults (poster #2.428),” Terence O'Brien, MD of the Royal Melbourne Hospital at The University of Melbourne presented new data from the completed Phase 2 STAR 1 (Synthetic Transdermal ...
Google PlusFacebookTwitterFlag as irrelevant
Zynerba Transdermal CBD Gel Data Suggest Significant Epilepsy Seizure Reductions in Adult ...
In a poster presentation entitled, “Synthetic Transdermal Cannabidiol for the Treatment of Focal Epilepsy in Adults (poster #2.428),” Terence O'Brien, ...
Google PlusFacebookTwitterFlag as irrelevant
Consistency key in growing strains of medical marijuana
The same is true for cannabidiol, or CBD, the other medicinal substance in marijuana that, in short, alters the way THC affects its user. Vireo, one of the companies newly permitted in Pennsylvania with plans for a marijuana growing facility in Scranton, offers five varieties of medicine with alternating ...
Google PlusFacebookTwitterFlag as irrelevant
WEB
Cannabidiol: An Overview of its Antipsychotic Properties
In this scenario, cannabidiol (CBD)—a nonpsychotomimetic compound of cannabis—emerges as a potential new therapeutic strategy to schizophrenia and other psychotic states. This chapter will discuss the latest evidence on CBD's antipsychotic profile, focusing on its discovery, and the subsequent ...
Google PlusFacebookTwitterFlag 
Comments